IPP Bureau
Lonza to build large-scale fill & finish facility in Switzerland
By IPP Bureau - July 07, 2022
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
Eugia Pharma receives USFDA approval for Triamcinolone Acetonide Injectable Suspension
By IPP Bureau - July 07, 2022
This is the 142nd ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.
NHA announces successful onboarding of 1 lakh+ healthcare facilities
By IPP Bureau - July 07, 2022
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Wacker to expand mRNA-based actives capacity at Halle, Germany
By IPP Bureau - July 06, 2022
Company is investing more than €100 million in the expansion of the Halle site
Merck launches international platform to discuss ‘Next-Gen Labs’
By IPP Bureau - July 06, 2022
Merck is organizing one of the biggest South APAC Virtual Conclave on ‘Next-Gen Labs’ on 20th July.
Cipla updates on US FDA product-specific pre-approval inspection
By IPP Bureau - July 06, 2022
The company has received 2 observations on FDA Form 483 with respect to ANDA filed for the product to be manufactured at Indore plant.
Biocon Biologics receives EU GMP Certification for its in Bengaluru
By IPP Bureau - July 06, 2022
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
Krsnaa Diagnostics opens diagnostics center at Moga, Punjab
By IPP Bureau - July 06, 2022
Krsnaa Diagnostics now has its footprints in Delhi.
Regeneron completes purchase of Sanofi's stake in Libtayo
By IPP Bureau - July 06, 2022
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
CEPI and Codiak BioSciences partner to develop protective Betacoronavirus vaccine
By IPP Bureau - July 06, 2022
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
Vacuubrand unveils new corporate identity
By IPP Bureau - July 06, 2022
VACUUBRAND has evolved rapidly in recent years, developing new innovative vacuum technology for laboratories, research and engineering
StimLabs announces new placental membrane-based product ‘Enverse’
By IPP Bureau - July 06, 2022
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance
By IPP Bureau - July 06, 2022
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Apollo Hospitals bags Waterfalls Global Award
By IPP Bureau - July 06, 2022
